+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Panacea Biotec Ltd (PANACEABIO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 49 Pages
  • September 2023
  • GlobalData
  • ID: 1367942
Panacea Biotec Ltd (PANACEABIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Panacea Biotec Ltd (Panacea) is a research-based health management company that research, develops, manufactures, distributes and markets pharmaceuticals, vaccines and biosimilars. Its vaccines portfolio includes trivalent and bivalent oral polio vaccine, and vaccines for diphtheria, tetanus, pertussis, Hepatitis B and haemophilus influenzae Type B. Its pharmaceutical formulations span across therapeutic areas, including oncology, nephrology, orthopedics, gastroenterology, pain management, diabetes, blood-related and organ transplantation, among others. The company also offers contract research and manufacturing services. Panacea operates manufacturing facilities in Baddi, Himachal Pradesh and Lalru, Punjab. It has presence in India, Switzerland, and Germany. Panacea is headquartered in New Delhi, India.

Panacea Biotec Ltd Key Recent Developments

  • Sep 07, 2023: Panacea Biotec Notice of 39Th Annual General Meeting
  • May 30, 2023: Panacea Biotec announces audited financial results for the quarter and year ended 31st March, 2023
  • Oct 12, 2022: CXV Global and Panacea Technologies combine to create leading provider of solutions optimizing life sciences operations
  • Apr 01, 2022: Appointment of Mr. Narotam Kumar Juneja as Non-Executive Non-Independent Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Panacea Biotec Ltd - Key Facts
  • Panacea Biotec Ltd - Key Employees
  • Panacea Biotec Ltd - Major Products and Services
  • Panacea Biotec Ltd - History
  • Panacea Biotec Ltd - Company Statement
  • Panacea Biotec Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Panacea Biotec Ltd - Business Description
  • Business Segment: Formulations
  • Overview
  • Performance
  • Business Segment: Vaccines
  • Overview
  • Performance
  • R&D Overview
  • Panacea Biotec Ltd - Corporate Strategy
  • Panacea Biotec Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Panacea Biotec Ltd - Strengths
  • Panacea Biotec Ltd - Weaknesses
  • Panacea Biotec Ltd - Opportunities
  • Panacea Biotec Ltd - Threats
  • Panacea Biotec Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Panacea Biotec Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 07, 2023: Panacea Biotec Notice of 39Th Annual General Meeting
  • May 30, 2023: Panacea Biotec announces audited financial results for the quarter and year ended 31st March, 2023
  • Oct 12, 2022: CXV Global and Panacea Technologies combine to create leading provider of solutions optimizing life sciences operations
  • Apr 01, 2022: Appointment of Mr. Narotam Kumar Juneja as Non-Executive Non-Independent Director
  • Mar 10, 2022: Panacea Bio : Resignation of Mr. Shantanu Yeshwant Nalavadi, Non-Executive Nominee Director of the Company
  • Feb 21, 2022: CEPI, THSTI and Panacea to develop vaccines for betacoronaviruses
  • Feb 14, 2022: Panacea Biotec Unaudited Financial Results for the quarter and nine months ended December 31, 2021
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Panacea Biotec Ltd, Key Facts
  • Panacea Biotec Ltd, Key Employees
  • Panacea Biotec Ltd, Major Products and Services
  • Panacea Biotec Ltd, History
  • Panacea Biotec Ltd, Other Locations
  • Panacea Biotec Ltd, Subsidiaries
  • Panacea Biotec Ltd, Joint Venture
  • Panacea Biotec Ltd, Key Competitors
  • Panacea Biotec Ltd, Ratios based on current share price
  • Panacea Biotec Ltd, Annual Ratios
  • Panacea Biotec Ltd, Interim Ratios
  • Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Panacea Biotec Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Panacea Biotec Ltd, Performance Chart (2019 - 2023)
  • Panacea Biotec Ltd, Ratio Charts
  • Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Lupin Ltd
  • Zydus Lifesciences Ltd
  • Dalas Biotech
  • Indus Biotech Pvt Ltd
  • GlaxoSmithKline Pharmaceuticals Ltd